Human medicines European public assessment report (EPAR): Glivec, imatinib, Date of authorisation: 07/11/2001, Revision: 51, Status: Authorised
EVVet3 EVWeb Production - Release notes
List of eligible industry stakeholder organisations
Highlights – Fourth EMA-Vaccines Europe bilateral meeting
Faecal microbiota transplantation EU-IN Horizon Scanning Report
Human medicines European public assessment report (EPAR): Datopotamab deruxtecan Daiichi Sankyo, datopotamab deruxtecan, Status: Application withdrawn
Human medicines European public assessment report (EPAR): Slenyto, melatonin, Date of authorisation: 20/09/2018, Revision: 14, Status: Authorised
Agenda - PCWP/HCPWP and all eligible organisations meeting 2025
Medicine shortage communication (MSC) : Beriglobin (human normal immunoglobulin), 2 mL and 5 mL solution for injection in pre-filled syringe: supply shortage and cessation of marketing (discontinuation)
Beriglobin